OUTLOOK THERAPEUTICS INC Asset Resilience Ratio

Latest as of June 2024: 0.00%

OUTLOOK THERAPEUTICS INC asset resilience ratio. OUTLOOK THERAPEUTICS INC (OTLK) has an Asset Resilience Ratio of 0.00% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See OUTLOOK THERAPEUTICS INC (OTLK) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

$1.00

Cash + Short-term Investments

Total Assets

$47.09 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of OUTLOOK THERAPEUTICS INC (None–None)

Asset resilience ratio of OUTLOOK THERAPEUTICS INC from None to None. This chart shows how OUTLOOK THERAPEUTICS INC's Asset Resilience Ratio has changed over time. Read OTLK total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down OUTLOOK THERAPEUTICS INC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see OTLK total asset value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$1.00	0.0%
Total Liquid Assets	$1.00	0.00%

Asset Resilience Insights

Limited Liquidity: OUTLOOK THERAPEUTICS INC maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

OUTLOOK THERAPEUTICS INC Industry Peers by Asset Resilience Ratio

Compare OUTLOOK THERAPEUTICS INC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
CSL Ltd AU:CSL	Biotechnology	0.41%
Genmab A/S CO:GMAB	Biotechnology	23.50%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	Biotechnology	1.69%
Abivax SA American Depositary Shares NASDAQ:ABVX	Biotechnology	4.91%
Bachem Holding AG SW:BANB	Biotechnology	0.00%
Viking Therapeutics Inc NASDAQ:VKTX	Biotechnology	72.03%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%

OUTLOOK THERAPEUTICS INC Asset Resilience Ratio by Year (None–None)

OUTLOOK THERAPEUTICS INC asset resilience ratio by year from None to None. The table below shows the annual Asset Resilience Ratio data for OUTLOOK THERAPEUTICS INC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About OUTLOOK THERAPEUTICS INC

NASDAQ:OTLK USA Biotechnology

Market Cap

$34.40 Million

Market Cap Rank

#23111 Global

#5070 in USA

Share Price

$0.47

Change (1 day)

-5.17%

52-Week Range

$0.20 - $2.47

All Time High

$867.20